Gentilly
France
7
2024-03-28
7
2024-08-06
These are the the leading inventors for applications assigned to SANOFI BIOTECHNOLOGY:
SANOFI BIOTECHNOLOGY based in Gentilly, FR has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:
Humanized anti-IL-1R3 antibody and methods of use
#2 | 2023-12-21 ✅ Patent 12,606,638 granted on 2026-04-21DOSING REGIMENS FOR USE WITH PCSK9 INHIBITORS
#3 | 2022-07-14 ✅ Patent 12,083,176 granted on 2024-09-10Human antibodies to PCSK9 for use in methods of treating particular groups of subjects
#4 | 2021-02-04 ✅ Patent 12,398,212 granted on 2025-08-26METHODS FOR TREATING OR PREVENTING ASTHMA BY ADMINISTERING AN IL-4R ANTAGONIST
#5 | 2020-12-31 ✅ Patent 12,440,561 granted on 2025-10-14METHOD OF DIAGNOSIS AND TREATMENT OF RHEUMATOID ARTHRITIS
#6 | 2020-12-24 ✅ Patent 12,297,279 granted on 2025-05-13Compositions and methods for treating pain in subjects with rheumatoid arthritis
#7 | 2018-01-18 ✅ Patent 11,845,800 granted on 2023-12-19Methods for treating or preventing asthma by administering an IL-4R antagonist
Also check out SANOFI BIOTECHNOLOGY's (Gentilly, France) applicant profile with 14 patent applications submitted.
608208 ⎘